Exponent, Inc. (NASDAQ:EXPO) Director Paul R. Johnston sold 8,008 shares of the stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $63.45, for a total value of $508,107.60. Following the completion of the transaction, the director now directly owns 96,515 shares in the company, valued at approximately $6,123,876.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Shares of EXPO stock traded up $0.42 during mid-day trading on Tuesday, hitting $63.41. 6,195 shares of the stock were exchanged, compared to its average volume of 177,928. The stock’s fifty day simple moving average is $64.23 and its two-hundred day simple moving average is $64.49. The company has a debt-to-equity ratio of 0.05, a quick ratio of 3.48 and a current ratio of 3.48. Exponent, Inc. has a 12-month low of $46.00 and a 12-month high of $72.70. The stock has a market capitalization of $3.29 billion, a price-to-earnings ratio of 50.76 and a beta of 0.38.
Exponent (NASDAQ:EXPO) last posted its earnings results on Thursday, October 17th. The business services provider reported $0.36 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.34 by $0.02. The business had revenue of $101.50 million during the quarter, compared to the consensus estimate of $100.17 million. Exponent had a return on equity of 23.62% and a net margin of 19.88%. The business’s quarterly revenue was up 6.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.32 EPS. On average, research analysts expect that Exponent, Inc. will post 1.5 earnings per share for the current fiscal year.
Several hedge funds have recently bought and sold shares of the company. Nuveen Asset Management LLC purchased a new position in Exponent in the 2nd quarter valued at $34,946,000. Morgan Stanley lifted its stake in shares of Exponent by 82.4% in the 2nd quarter. Morgan Stanley now owns 359,112 shares of the business services provider’s stock worth $21,023,000 after acquiring an additional 162,208 shares during the period. Conestoga Capital Advisors LLC lifted its stake in shares of Exponent by 4.4% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 2,422,012 shares of the business services provider’s stock worth $141,785,000 after acquiring an additional 102,845 shares during the period. Nicholas Company Inc. purchased a new stake in shares of Exponent in the second quarter valued at about $5,204,000. Finally, Moody Aldrich Partners LLC purchased a new stake in shares of Exponent in the second quarter valued at about $3,767,000. 88.72% of the stock is owned by institutional investors and hedge funds.
A number of brokerages have issued reports on EXPO. William Blair reaffirmed a “market perform” rating on shares of Exponent in a report on Friday, October 18th. BidaskClub downgraded Exponent from a “hold” rating to a “sell” rating in a report on Thursday, October 24th. ValuEngine downgraded Exponent from a “hold” rating to a “sell” rating in a report on Wednesday, October 2nd. DA Davidson initiated coverage on shares of Exponent in a research report on Wednesday, August 28th. They set a “neutral” rating for the company. Finally, SunTrust Banks upped their target price on shares of Exponent from $70.00 to $81.00 and gave the company a “buy” rating in a report on Friday, September 20th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $76.75.
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Further Reading: How Do You Make Money With Penny Stocks?
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.